IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DAVID P SCHENKEIN

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1144330176
CMS profile
1050699
Location
BOSTON, MA

General Payments · PY2019–2024

$4,043,987.05

  • Reported across 124 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$829,811.81

47 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Internal Medicine MA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $455,742.97 11
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $360,000.00 2
Travel and Lodging $12,220.85 6
Food and Beverage $1,847.99 28

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Agios Pharmaceuticals, Inc. $403,125.00 5
Regeneron Pharmaceuticals, Inc. $303,039.40 39
BeiGene, Ltd. $123,626.79 2
Cortex, Inc. $20.62 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $735.68 4
PY2020 $749,904.24 17
PY2021 $261,458.38 15
PY2022 $574,323.86 16
PY2023 $1,627,753.08 25
PY2024 $829,811.81 47

Payment records · PY2024 (47)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Agios Pharmaceuticals, Inc. $14,375.00 02/21/2024 Consulting Fee Undisputed 01/23/2026 1149646392 CMS
Agios Pharmaceuticals, Inc. $14,375.00 05/15/2024 Consulting Fee Undisputed 01/23/2026 1149641694 CMS
Agios Pharmaceuticals, Inc. $270,000.00 06/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1149643192 CMS
Agios Pharmaceuticals, Inc. $90,000.00 06/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1149645574 CMS
Agios Pharmaceuticals, Inc. $14,375.00 07/10/2024 Consulting Fee Undisputed 01/23/2026 1149644773 CMS
BeiGene, Ltd. $3,750.00 03/05/2024 Consulting Fee Undisputed 01/23/2026 1120844970 CMS
BeiGene, Ltd. $119,876.79 12/31/2024 Consulting Fee Undisputed 01/23/2026 1120844973 CMS
Cortex, Inc. $20.62 04/02/2024 Food and Beverage Undisputed 01/23/2026 1117311304 CMS
Regeneron Pharmaceuticals, Inc. $151,680.90 01/02/2024 Consulting Fee Undisputed 01/23/2026 1114404595 CMS
Regeneron Pharmaceuticals, Inc. $37,310.28 01/02/2024 Consulting Fee Undisputed 01/23/2026 1114404597 CMS
Regeneron Pharmaceuticals, Inc. $25,000.00 01/03/2024 Consulting Fee Undisputed 01/23/2026 1114404599 CMS
Regeneron Pharmaceuticals, Inc. $37.38 01/26/2024 Food and Beverage Undisputed 01/23/2026 1114404601 CMS
Regeneron Pharmaceuticals, Inc. $17.16 01/26/2024 Food and Beverage Undisputed 01/23/2026 1114404603 CMS
Regeneron Pharmaceuticals, Inc. $7.77 01/26/2024 Food and Beverage Undisputed 01/23/2026 1114404605 CMS
Regeneron Pharmaceuticals, Inc. $1,530.42 01/27/2024 Travel and Lodging Undisputed 01/23/2026 1114404607 CMS
Regeneron Pharmaceuticals, Inc. $319.73 01/30/2024 Food and Beverage Undisputed 01/23/2026 1114404609 CMS
Regeneron Pharmaceuticals, Inc. $22.35 01/31/2024 Food and Beverage Undisputed 01/23/2026 1114404611 CMS
Regeneron Pharmaceuticals, Inc. $25,000.00 04/03/2024 Consulting Fee Undisputed 01/23/2026 1114404613 CMS
Regeneron Pharmaceuticals, Inc. $27.94 04/04/2024 Food and Beverage Undisputed 01/23/2026 1114404615 CMS
Regeneron Pharmaceuticals, Inc. $24.08 04/04/2024 Food and Beverage Undisputed 01/23/2026 1114404617 CMS
Regeneron Pharmaceuticals, Inc. $12.82 04/04/2024 Food and Beverage Undisputed 01/23/2026 1114404619 CMS
Regeneron Pharmaceuticals, Inc. $55.24 04/05/2024 Food and Beverage Undisputed 01/23/2026 1114404621 CMS
Regeneron Pharmaceuticals, Inc. $253.13 04/05/2024 Food and Beverage Undisputed 01/23/2026 1114404623 CMS
Regeneron Pharmaceuticals, Inc. $19.30 04/05/2024 Food and Beverage Undisputed 01/23/2026 1114404625 CMS
Regeneron Pharmaceuticals, Inc. $1,605.14 04/08/2024 Travel and Lodging Undisputed 01/23/2026 1114404627 CMS
Regeneron Pharmaceuticals, Inc. $19.30 06/06/2024 Food and Beverage Undisputed 01/23/2026 1114404629 CMS
Regeneron Pharmaceuticals, Inc. $36.44 06/14/2024 Food and Beverage Undisputed 01/23/2026 1114404631 CMS
Regeneron Pharmaceuticals, Inc. $53.50 06/14/2024 Food and Beverage Undisputed 01/23/2026 1114404633 CMS
Regeneron Pharmaceuticals, Inc. $11.66 06/17/2024 Food and Beverage Undisputed 01/23/2026 1114404635 CMS
Regeneron Pharmaceuticals, Inc. $1,533.00 06/17/2024 Travel and Lodging Undisputed 01/23/2026 1114404637 CMS
Regeneron Pharmaceuticals, Inc. $25,000.00 07/03/2024 Consulting Fee Undisputed 01/23/2026 1114404639 CMS
Regeneron Pharmaceuticals, Inc. $19.30 09/09/2024 Food and Beverage Undisputed 01/23/2026 1114404641 CMS
Regeneron Pharmaceuticals, Inc. $48.53 09/13/2024 Food and Beverage Undisputed 01/23/2026 1114404643 CMS
Regeneron Pharmaceuticals, Inc. $5,458.96 09/13/2024 Travel and Lodging Undisputed 01/23/2026 1114404645 CMS
Regeneron Pharmaceuticals, Inc. $532.54 09/16/2024 Travel and Lodging Undisputed 01/23/2026 1114404647 CMS
Regeneron Pharmaceuticals, Inc. $18.93 09/17/2024 Food and Beverage Undisputed 01/23/2026 1114404649 CMS
Regeneron Pharmaceuticals, Inc. $25,000.00 10/02/2024 Consulting Fee Undisputed 01/23/2026 1114404651 CMS
Regeneron Pharmaceuticals, Inc. $363.99 11/08/2024 Food and Beverage Undisputed 01/23/2026 1114404653 CMS
Regeneron Pharmaceuticals, Inc. $17.92 11/14/2024 Food and Beverage Undisputed 01/23/2026 1114404655 CMS
Regeneron Pharmaceuticals, Inc. $25.90 11/14/2024 Food and Beverage Undisputed 01/23/2026 1114404657 CMS
Regeneron Pharmaceuticals, Inc. $27.17 11/14/2024 Food and Beverage Undisputed 01/23/2026 1114404659 CMS
Regeneron Pharmaceuticals, Inc. $8.94 11/14/2024 Food and Beverage Undisputed 01/23/2026 1114404661 CMS
Regeneron Pharmaceuticals, Inc. $316.97 11/14/2024 Food and Beverage Undisputed 01/23/2026 1114404663 CMS
Regeneron Pharmaceuticals, Inc. $32.66 11/14/2024 Food and Beverage Undisputed 01/23/2026 1114404665 CMS
Regeneron Pharmaceuticals, Inc. $20.32 11/15/2024 Food and Beverage Undisputed 01/23/2026 1114404667 CMS
Regeneron Pharmaceuticals, Inc. $1,560.79 11/18/2024 Travel and Lodging Undisputed 01/23/2026 1114404669 CMS
Regeneron Pharmaceuticals, Inc. $8.94 11/20/2024 Food and Beverage Undisputed 01/23/2026 1114404671 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.